United Services Automobile Association’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-39,928
Closed -$1.84M 2269
2018
Q4
$1.84M Sell
39,928
-1,229
-3% -$59.2K 0.01% 1075
2018
Q3
$1.83M Sell
41,157
-404
-1% -$18.5K ﹤0.01% 1161
2018
Q2
$1.63M Buy
41,561
+38,171
+1,126% +$1.93M ﹤0.01% 1203
2018
Q1
$245K Buy
+3,390
New +$249K ﹤0.01% 1991
2017
Q1
Sell
-35,280
Closed -$442K 1330
2016
Q4
$442K Hold
35,280
﹤0.01% 1237
2016
Q3
$489K Hold
35,280
﹤0.01% 1214
2016
Q2
$349K Hold
35,280
﹤0.01% 1225
2016
Q1
$597K Hold
35,280
﹤0.01% 1132
2015
Q4
$785K Hold
35,280
﹤0.01% 1118
2015
Q3
$832K Buy
35,280
+6,800
+24% +$427K ﹤0.01% 1098
2015
Q2
$2.33M Hold
28,480
0.01% 947
2015
Q1
$2.64M Buy
+28,480
New +$1.84M 0.01% 904

Other funds holding ESPR

United Services Automobile Association's ESPR Position: Q1 2019 in Review

United Services Automobile Association sold out of Esperion Therapeutics (ESPR) in Q1 2019, closing a stake of 39,928 shares — an estimated $1.84M sold.

United Services Automobile Association first reported a position in ESPR in Q1 2015 and held it in 12 quarters. The position peaked at $2.64M in Q1 2015. 163 funds tracked by Wall St. Rank hold ESPR as of Q1 2019.

  • United Services Automobile Association reported no remaining Esperion Therapeutics position as of Q1 2019 after selling out during the quarter.
  • United Services Automobile Association sold 39,928 Esperion Therapeutics shares in Q1 2019, an estimated $1.84M.
  • United Services Automobile Association first reported a position in Esperion Therapeutics in Q1 2015 and held it in 12 quarters.
  • United Services Automobile Association's Esperion Therapeutics position peaked at $2.64M in Q1 2015.
  • 163 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2019.

Based on United Services Automobile Association's 13F filing for Q1 2019, filed 13 May 2019.